ERBB2 and breast cancer: Accordingly, studying the TME of 207 patients with BC (Luminal A, Luminal B, HER2, Triple-negative), Chen and coworkers examined the frequency of IL-17 secreting cells and its association with pathological and clinical features by immunohistochemical assay.